Close Menu
Home » U of Manchester to Run Abcodia Lung Cancer Collaboration From New $27M Biomarker Discovery Center

U of Manchester to Run Abcodia Lung Cancer Collaboration From New $27M Biomarker Discovery Center

Aug 20, 2015
|
Adam Bonislawski
Premium

NEW YORK (GenomeWeb) – The University of Manchester is collaborating with UK-based diagnostics firm Abcodia to identify protein biomarkers for risk stratification and early detection of lung cancer.

The effort is one of a series of biomarker development projects the university will run out of the Stoller Biomarker Discovery Centre that it plans to open next year supported by £17 million ($27 million) in funding largely from the UK's Medical Research Council.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Hundreds and Hundreds Retracted

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

Guilty Plea in Kickback Case

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

Florida Bill Moves Ahead

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

Science Presents Studies Into Disease-Causing Mutations Among Bone Marrow Donors; Links Between Heavy Drinking, Other Disease

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.

What's Popular?

In Proteomics & Protein Research

  1. The Decade in Proteomics: Most Significant Informatics Developments

    Premium

  2. The Decade in Proteomics: Most Significant New Instrumentation

    Premium

  3. Fluidigm Anticipates Flat Q4 Revenues

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.